P. Cristoforoni

发表

Computerized Colposcopy: Results of a Pilot Study and Analysis of Its Clinical Relevance

P. Cristoforoni, D. Gerbaldo, A. Perino, 1995, Obstetrics and gynecology.

Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: a multicenter, retrospective, observational pilot study in Italy.

P. Cristoforoni, G. Scambia, G. Ferrandina, 2011, Clinical therapeutics.

Sentinel Pap smears in 261 invasive cervical cancer patients in Italy.

P. Cristoforoni, A. Maggioni, M. Sideri, 2009, Vaccine.

Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series.

P. Cristoforoni, M. Tommasino, M. Sideri, 2009, Vaccine.

Endogenous versus exogenous IL-10 in postoperative intraperitoneal adhesion formation in a murine model.

P. Cristoforoni, F. Montz, C. Holschneider, 1997, The Journal of surgical research.

Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma

L. Mariani, P. Cristoforoni, S. Costa, 2015, Ecancermedicalscience.

Anti-interleukin-10: Effect on Postoperative Intraperitoneal Adhesion Formation in a Murine Model

P. Cristoforoni, F. Montz, C. Holschneider, 1997 .

Surgical approach and long-term clinical outcome in women with microinvasive cervical cancer.

P. Cristoforoni, A. Ciavattini, F. Sopracordevole, 2014, Anticancer research.

Overview of the benefits and potential issues of the nonavalent HPV vaccine

L. Mariani, P. Cristoforoni, M. Preti, 2017, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Effects of Human Papillomavirus‐Associated Cells on Human Immunodeficiency Virus Gene Expression

P. Cristoforoni, F. Montz, O. Martínez-Maza, 2000, Obstetrics and gynecology.

Morphological Aspects of Human Endometrium during Hormone Replacement Therapy

P. Cristoforoni, D. Gerbaldo, E. Fulcheri, 1994, Annals of the New York Academy of Sciences.

Frequency and cause of aborted laparoscopic-assisted vaginal hysterectomy.

P. Cristoforoni, D. Gerbaldo, F. Montz, 1995, The Journal of the American Association of Gynecologic Laparoscopists.

Cytological analysis of the distension fluid used during diagnostic office hysteroscopies in patients with suspected endometrial pathology.

P. Cristoforoni, D. Gerbaldo, N. Ragni, 2005, European journal of gynaecological oncology.

Interleukin (IL)‐18, a biomarker of human ovarian carcinoma, is predominantly released as biologically inactive precursor

S. Canevari, P. Cristoforoni, M. Gualco, 2011, International journal of cancer.

VIN usual type—from the past to the future

L. Mariani, P. Cristoforoni, S. Costa, 2015, ecancermedicalscience.

HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions

L. Mariani, P. Cristoforoni, S. Costa, 2016, Journal of Cancer.

Extending Human Papillomavirus (HPV) vaccination beyond female adolescents and after treatment for high grade CIN: the Italian HPV Study Group (IHSG) review and position paper.

L. Mariani, P. Cristoforoni, S. Costa, 2020, European review for medical and pharmacological sciences.

[HPV vaccination: not only female adolescents and not only prophylactic. Review and position paper of the Italian HPV Study Group (IHSG)].

L. Mariani, P. Cristoforoni, S. Costa, 2019, Minerva ginecologica.

E6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): a promising perspective

L. Mariani, P. Cristoforoni, S. Costa, 2015, Ecancermedicalscience.

HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice

L. Mariani, P. Cristoforoni, S. Costa, 2012, Ecancermedicalscience.

Effect of new investigational drug taxol on oncolytic activity and stimulation of human lymphocytes

P. Cristoforoni, J. Wharton, E. Lotzová, 1993, Gynecologic oncology.

Operative Hysteroscopy Ten Years' Experience

P. Cristoforoni, A. Perino, N. Chianchiano, 1994, Annals of the New York Academy of Sciences.

Reductive surgery and ovarian function in the human--can reductive ovarian surgery in reproductive age negatively influence fertility and age at onset of menopause?

P. Cristoforoni, S. Chiodi, G. Ravera, 1995, International journal of fertility and menopausal studies.

Second-Line Treatment with Intravenous Gemcitabine and Oral Etoposide in Platinum-Resistant Advanced Ovarian Cancer Patients: Results of a Phase II Study

D. Merlo, P. Cristoforoni, M. Ferrarini, 2011, Oncology.

Adhesion Formation Following Incisional Hernia Repair: A Randomized Porcine Trial

P. Cristoforoni, F. Montz, Y. B. Kim, 1997 .

The incidental finding of abnormal cervical histology in postmenopausal patients.

P. Cristoforoni, D. Gerbaldo, E. Fulcheri, 1995, Maturitas.

Folinic acid in the treatment of human male infertility.

P. Cristoforoni, G. Bentivoglio, F. Mélica, 1993, Fertility and sterility.

Human papillomavirus DNA and Pap tests: the need for cotesting in opportunistic setting during the transition time.

L. Mariani, P. Cristoforoni, S. Costa, 2013, Journal of lower genital tract disease.

Management of the abnormal papanicolaou smear during pregnancy: lessons for quality improvement.

P. Cristoforoni, D. Gerbaldo, F. Montz, 1999, Journal of lower genital tract disease.

Interleukin (IL)‐18, a biomarker of human ovarian carcinoma, is predominantly released as biologically inactive precursor

S. Canevari, P. Cristoforoni, M. Gualco, 2011, International journal of cancer.